Talis Biomedical Corp Human Resources Contracts & Agreements
15 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Change of Control Agreements (2)
- Compensation Agreements (3)
- Consulting Agreements (1)
- Retention Agreements (5)
- Retention Agreement, dated August 19, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated August 19, 2024, by and between the Company and Robert Kelley, Chief Executive Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on May 8, 2024)
- Retention Agreement, dated November 13, 2023, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on November 14, 2023)
- Talis Biomedical Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 2, 2022)
- Talis Biomedical Corporation 2021 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on August 2, 2022)
- Talis Biomedical Corporation Severance and Change in Control Plan and Amended Form of Participation Agreement thereunder (Filed With SEC on March 15, 2022)
- Talis Biomedical Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Talis Biomedical Corporation 2021 Equity Incentive Plan (Filed With SEC on November 16, 2021)
- Separation and Consulting Agreement by and between the Registrant and Brian Coe, dated August 30, 2021 (Filed With SEC on November 16, 2021)
- Talis Biomedical Corporation Severance and Change in Control Plan (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation Non-Employee Director Compensation Policy (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation 2013 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on January 22, 2021)
